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Abstract: Introduction: Differentiation between thyroiditis induced thyrotoxicosis and Graves' disease is important for 
selection of proper therapy. It is often difficult to make this distinction without performing thyroid scintigraphy. Color flow 
Doppler sonography (CFDS) is gaining importance for the functional evaluation of the thyroid disorders. We aimed to 
determine the value of CFDS for the etiological diagnosis of thyrotoxicosis. 
Patients and methods: Thirty patients with clinical and lab signs of hyperthyroidism (12 Graves’ disease and, 18 patients 
with Hashimoto’s thyroiditis) with 10 euthyroid controls were evaluated.Etiological diagnosis was carried out using 
standard methods. Conventional grey scale sonography was done, followed by CFDS. Doppler patterns of the glands 
were scored and peak systolic velocity (PSV) measurements were obtained from superior and inferior thyroid arteries. 
Results were correlated to isotope scanning which was used as a golden standard.  
Results: Vascular patterns were significantly more prominent, and the mean PSV values were significantly higher in the 
Graves' Disease patients compared to the thyroiditis patients than controls. CFDS could differentiate the untreated 
Graves' Disease from the thyroiditis which had similar grey scale findings but higher vascular patterns and significantly 
higher PSV values, sensitivity = 96.6%, specificity= 96.6 %, and P>0.001 
Conclusion: As an inexpensive, fast, and noninvasive imaging procedure, CFDS could be helpful in the initial clinical 
evaluation and may avoid scintigraphy in a substantial number of thyrotoxic patients. 
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INTRODUCTION 
High resolution ultrasonography has become the 
first-line method in the evaluation of thyroid morphology 
due to its high sensitivity and ease of use [1]. 
Thyroid scintigraphy is the conventionally accepted 
method in the functional evaluation of the thyroid gland. 
Nowadays, color flow Doppler sonography (CFDS) also 
plays an important role in obtaining functional informa- 
tion. CFDS is a powerful technique combining the gray 
scale view of the conventional sonography with a color 
display of blood flow. This provides an evaluation of the 
vascular patterns of the thyroid gland, which may be an 
indirect measure of thyroid function. CFDS applications 
depend on quantitative and qualitative analyses. Peak 
systolic velocity (PSV) obtained from the main thyroid 
arteries is the parameter commonly employed for the 
quantitative Doppler evaluation of the thyroid gland. 
Measurements are usually obtained from the superior 
thyroidal arteries (STA) or the inferior thyroidal arteries 
(ITA). It is determined as the recorded Doppler wave of 
the point at which the highest frequency shift is 
observed in the images [1]. 
Qualitatively, various classifications of vascular 
patterns have been proposed, some of which overlap. 
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Among these, the classification of Vitti et al. [3] for the 
diffuse goiter is one of the most popular ones in the 
literature (Table 1). Healthy glands show either no color 
signals in the parenchyma or occasional intra-
parenchymal spots. Blood flow limited to peripheral 
thyroidal arteries is normal [1]. 
The basic principle of CFDS depends on its ability 
to distinguish autoimmune hyperthyroidism 
(Hashimoto's thyroiditis) from other low radioiodine 
uptake causes of hypothyroidism. As supported by 
many studies, the thyroid gland’s vascular signals are 
found to be increased in hyperthyroidism, whereas they 
are normal or decreased in the latter [1-3].  
 The aim of the study is to determine the value of 
CFDS in the differentiation between Graves' disease 
and Hashimoto's thyroiditis induced hyperthyroidism. 
PATIENTS AND METHODS 
Our study was approved by the ethical commitee of 
our hospitals and informed consent was obtained from 
all participants. Forty patients, 17 male and 23 females 
with (12 Graves’ disease, 18 patients with thyroiditis, 
and 10 euthyroid controls) having clinical and lab signs 
of hyperthyroidism were referred from the period July 
2013 to February 2014 to a private centre for 
sonographic and color flow Doppler differentiation 
between Graves' disease and toxic phase of 
Hashimoto's thyroiditis because both have the same 
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clinical picture but different management and prog- 
nosis. All of the cases were newly diagnosed and did 
not receive therapy or any other medication that could 
affect thyroid vascularization. 
 Etiological diagnosis was carried out by measuring 
serum thyroid hormones, serum thyroid stimulating 
hormone (sTSH) levels, and auto-antibody levels. 
Conventional 
B mode-gray scale ultrasonography, followed by 
CFDS was performed in all of the cases, and blood 
flow patterns were evaluated. 
The thirty patients with hyperthyroidism performed a 
routine 99mTc thyroid scans with injected I.V dose of 3-
5 mCi according to body weight using Philips 
Merredian scanner (Philips, Amesterdam, The Nether- 
lands) in the same centre and was used as a gold 
standard. 
The hyperthyroidism group consisted of patients 
with high free T3 and T4 In this group of patients, those 
with sTSH value less than 0.1 mIU/ mL, diffuse high 
tracer uptake in the thyroid scan, and positive thyroid 
autoantibody tests (antithyroglobulin [anti-Tg]>60U/mL, 
anti–thyroid peroxidase [anti-TPO]>60U/mL)] were 
diagnosed as Graves' Disease.  
Thyroiditis was diagnosed by demonstrating the 
heterogeneous echogenicity of the thyroid parenchyma 
by ultrasonography, positivity of at least one of the 
thyroid auto-antibodies as described above, together 
with normal or increased sTSH serum levels with poor 
tracer uptake in the thyroid scan. 
Cases with sTSH values between 0.35 and 5.5 
mIU/mL, normal serum thyroid hormone levels, and 
negative thyroid auto-antibodies, served as controls. 
B-mode and colour Doppler ultrasonography 
examination: 
Conventional ultrasonography and CFDS were 
performed by using a 7–11 MHz broadband linear 
transducer Xario (Toshiba, Yokohama, Japan). 
Echogenicity of the thyroid parenchyma was graded as 
diffuse homogeneous or mild, moderate, or extremely 
heterogeneous in grey scale and the color gain was 
adjusted so that artifacts were prevented. The 
sonographic study was performed with the patient in 
dorsal decubitus with a cushion under the shoulders 
and the neck hyper-extended. In order not to 
underestimate the vascularization intensity, the probe 
was lightly positioned on the skin without any 
compression. A short apnea was requested from the 
patients during the duplex-color Doppler recordings. 
Color Doppler parameters were standardized and, for 
all studies, the same presets were used for the 
acquisition. The equipment was set up to ‘‘thyroid’’, 
configured as follows: PRF (pulse repetition frequency) 
700 Hz, colour map 1, WF (wall filter) medium and flow 
option medium 
Velocity. In addition, the gain settings (between 72 
and 79) were adjusted to avoid background noise. The 
probe was positioned in the longitudinal and horizontal 
directions, with its centre at the middle third of the 
thyroid lobes. The isthmus vascularization was also 
included. For PSV measurements, the sampling 
volume was adjusted to 3mm at the center of the 
vessel. For evaluation of the superior thyroid artery 
(STA), the probe was positioned in the oblique sagittal 
plane, close to the superior thyroid pole. The inferior 
thyroid artery was examined in the oblique transversal 
plane, close to the transition between the medium and 
the inferior third of the thyroid. The cursor for 
evaluation of the inferior thyroid artery (ITA) was set 
close to the trachea in order to avoid artifacts coming 
from the common carotid artery and the internal jugular 
vein. The peak systolic velocity (PSV) and resistive 
index (RI) values in the superior and inferior thyroid 
arteries were obtained. The Doppler angle was 
corrected to values under or equal to 60°.The mean 
value found in the right and left lobes was used as a 
representative parameter. The limits of normal PSV 
values are generally accepted as 25–30cm/s for STA 
and 23–25 cm/s for ITA [4, 14]. 
The vascular patterns of the thyroid gland were 
scored for the parenchyma according to the Vitti’s 
classification.  
Table 1: Vitti’s Classifications of Color Flow Doppler 
Sonography Patterns 
Description Pattern 
- Blood flow limited to the peripheral thyroid arteries  
  or to subcapsular vessels. 
- Mildly increased color signals at the level of peripheral  
  thyroid arteries and presence of parenchymal blood  
  flow with patchy, uneven distribution. 
- Clearly increased color flow Doppler signal with patchy  
  distribution. 
- Markedly increased color flow Doppler signals with  
  diffuse homogeneous distribution included the  
  ‘‘thyroid inferno’’ 
0 
  
I 
 
 II 
 
 III 
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RESULTS 
Laboratory data of the study groups are 
summarized in Table 2. Vascular signal patterns were 
significantly more prominent, and the mean PSV values 
were significantly higher in the Graves' Disease group 
compared to the Thyroiditis and control (Table 3). 
Correlation analysis between CFDS parameters and 
thyroid function tests revealed that there is a significant 
correlation between free T3 and PSV values in the 
Graves' disease group. There was a positive 
correlation between intrathyroidal vascular markings in 
the Graves' disease and thyroiditis group. Similarly, we 
determined significant correlations thyroidal PSV 
measurements in both the Graves' disease and 
thyroiditis group; there was no correlation in the control 
group regarding these parameters.  
Parenchymal echo patterns differed significantly 
when the Graves' disease group was compared with 
the control group and the thyroiditis group. Similarly, 
the difference in parenchymal echo patterns was 
significant between the control and thyroiditis groups. A 
positive correlation was determined between 
parenchymal echo patterns and some Doppler 
parameters in the Graves' disease group. Thus, 
increasing echo correlated with increasing thyroidal 
PSV values as well as more prominent intrathyroidal 
CFDS patterns. When correlated to thyroid scan, colour 
doppler sonography showed sensitivity = 96.6% and 
specificity 96.6%, and P>0.001. 
Table 2: Summary of the Laboratory Results of the 
Study Groups 
 Number 
of Cases 
sTSH 
mIU/L 
Free T3  
Ngm/ml 
Anti 
Thyroglobulin 
U/ml 
Graves' 
disease 
 12 0.05 +/- 
0.08 
18 +/-5 500 +/- 150 
thyroiditis  18 5.50 +/-
2 
4 +/- 1 225 +/- 100 
Control  10 1.50 +/- 
0.5 
6 +/- 2 20 +/- 10 
 
Table 3: Summary of the Doppler Findings in the Study 
Groups 
 Number 
of Cases 
Color Doppler Flow 
Pattern 
0       I        II        III 
Mean PSV 
(cm/sec) 
Graves' 
disease 
12                    5         7 75 +/- 25 
Thyroiditis 18          2       13       3 40 +/- 20  
Diffuse goiter 10    8      2 25 +/- 15 
DISCUSSION 
The characteristic grey scale ultrasonographic and 
CFDS findings of Graves' disease patients in our study 
are generally in accord with the literature [2,6,12]. In 
one of the Doppler studies, Vitti et al. [3] have 
evaluated CFDS patterns and PSV values of treated 
and untreated Graves' disease and thyroiditis patients. 
 
 
  
 
 
 
  (a)     (b)     (C) 
(a) grey scale B mode ultrasound showing homogeneous texture of the gland (b) color doppler image showing normal intra thyroid vascularity 
(grade 0) (c) pulsed doppler of the ITA showing normal PSV (19 cm/sec) and RI (0.57). 
 
Case 1: 38 yrs female with mild diffuse goiter, normal T3, TSH serving as a control. 
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(c) (d) 
 
 
 
 
 
 
(a) Grey scale B mode ultrasound showing heterogeneous texture of the gland with coarseness. (b) color doppler image showing increased intra 
thyroid vascularity (grade III). (c) pulsed doppler of the ITA showing high PSV (99 cm/sec) and low RI (0.49). (d) thyroid scan showing typical 
features of Graves' disease with uptake = 19 %. 
Case 2: 34 yrs female Graves' disease with high free T3, low TSH and increased anti thyrogloblin antibodies. 
(a) (b) 
 
 
 
 
 
(c) (d) 
 
 
 
 
 
(a) grey scale B mode ultrasound showing inhomogeneous texture of the gland with fine coarseness. (b) color doppler image showing increased 
intra thyroid vascularity (grade II). (c) pulsed doppler of the ITA showing high PSV (40 cm/sec) and low RI (0.42). (d) thyroid scan showing 
typical features of thyroiditis with uptake = 0.1 %. 
Case 3: 45 yrs male, thyroiditis with increased T3, high TSH and increased anti thyroglobulin. 
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They have discovered clear relationships between 
patients’ functional status and CFDS parameters. They 
found pattern III vascular signals (‘‘thyroid inferno’’), 
previously described by Ralls et al. [9], in the majority 
of the untreated Graves' disease patients (Table 1). 
Similar findings were reported by Bogazzi et al. in 
untreated Graves' disease patients [8]. 
Most of our untreated Graves' disease patients 
corresponded to pattern III, but not II of Vitti’s 
classification (Table 1). CFDS could generally different- 
iate the untreated Graves' disease patients from diffuse 
goiter, but more importantly from the patients with 
thyroiditis (who have similar grey scale ultrasono- 
graphic findings) (Table 3). 
However, we have observed a few overlaps of 
CFDS patterns between Graves' disease and thyroiditis 
patients that are also supported by the literature [3,8]. 
Our findings suggest that, although what is described 
as thyroid inferno is seen in some of the untreated 
cases, it is neither pathognomonic nor specific for 
untreated Graves' disease and could also be seen in 
thyroiditis. 
PSV measurements, obtained from both STA and 
ITA vessels, were also significantly higher in Graves' 
disease patients when compared with the other diffuse 
groups. This parameter could help to differentiate the 
overlapping Doppler patterns observed in the Graves' 
disease and thyroiditis groups [3,8,13]. PSV 
measurement seems to be more useful than evaluation 
of CFDS patterns in the differential diagnosis of 
autoimmune thyroid disorders. Contrary to our findings, 
PSV values of thyroiditis patients with hyperthyroidism 
have been found to be significantly higher than their 
euthyroid counterpart in some of the literature [5,8]; 
however, they were still lower than those of untreated 
Graves' disease patients, which we also found [7]. In 
accordance with our findings, Vitti et al. [3] could not 
determine any correlations between sTSH levels and 
Doppler parameters in the thyroiditis group. In a recent 
paper, Schulz et al. [11] have reported the results of 89 
patients with Hashimoto's thyroiditis. They observed 
Vitti pattern III in six of the cases, and pattern II in 11 of 
their patients. Increased signal intensity was explained 
as a part of ongoing autoimmune process but not by 
serum sTSH levels. They found strong positive 
correlations between Doppler patterns and PSV values 
and serum thyroid autoantibody levels. However, most 
of their cases were under treatment, and any possible 
effect of the therapy on vascular signals has to be 
taken into account. Regarding intrathyroidal signals, 
Bogazzi et al. [8] have made PSV measurements from 
intrathyroidal arteries in untreated Graves' disease 
cases, and reported mean values of 65cm/s. This value 
was 75cm/s in our group. Our Hashimoto's thyroiditis 
patients’ values were also higher than this group (40 
cm/s vs. 35 cm/s). These differences may result from 
variations in measurement methods or devices used 
[10, 15]. 
Our results are in coordinance with Donkol et al [16] 
and Sekulic et al [17], both showed good correlation 
between color duplex sonography and Tc 99m thyroid 
scan in differentiating Graves' disease from thyroiditis.  
CONCLUSION 
CFDS could provide important information about the 
functional state of the thyroid gland and could be used 
in all endocrinology departments as a part of clinical 
evaluation of thyrotoxic patients. It can help strikingly in 
differentiation of Graves’ disease, nontoxic diffuse 
goiter, and Hashimoto’s thyroiditis.. Finally, CFDS 
could avoid scintigraphy in a substantial number of 
thyrotoxic patients during the routine clinical work-up. 
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